================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-K
------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JULY 15, 2005
LEXICON GENETICS INCORPORATED
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<Table>
DELAWARE 000-30111 76-0474169
(STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
</Table>
8800 TECHNOLOGY FOREST PLACE
THE WOODLANDS, TEXAS 77381
(ADDRESS OF PRINCIPAL EXECUTIVE
OFFICES AND ZIP CODE)
(281) 863-3000
(REGISTRANT'S TELEPHONE NUMBER,
INCLUDING AREA CODE)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On July 15, 2005, we entered into an Economic Development Agreement
(the "Economic Development Agreement") with the State of Texas and the Texas A&M
University System ("TAMUS") and a Collaboration and License Agreement with TAMUS
and the Texas Institute for Genomic Medicine ("TIGM").
Under the Economic Development Agreement, we will receive $35 million
from the Texas Enterprise Fund for the creation of a knockout mouse embryonic
stem cell library containing 350,000 cell lines using our proprietary gene
trapping technology. The library will be created for TIGM, a newly formed
non-profit institute whose founding members are Texas A&M University, the Texas
A&M Health Science Center and us. TIGM researchers may also access specific
cells from our current gene trap library of 270,000 mouse embryonic stem cell
lines and will have certain rights to utilize our patented gene targeting
technologies. In addition, we will equip TIGM with the bioinformatics software
required for the management and analysis of data relating to the library. The
Texas Enterprise Fund has also awarded $15 million to TAMUS for the creation of
facilities and infrastructure to house the library.
Under the Economic Development Agreement, we are responsible for the
creation of a specified number of jobs, reaching an aggregate of 1,616 new jobs
in Texas by December 31, 2015. Certain offsets for surplus jobs created and
credits for funding received by TIGM and certain related parties from sources
other than the State will reduce our jobs responsibility. If we fail to reach
such specified job levels, the State may require us to repay $2,415 for each job
we fall short. Our maximum aggregate exposure for such payments, if we fail to
create any new jobs, is approximately $14.4 million. TAMUS, together with TIGM,
has independent job creation obligations under the Economic Development
Agreement and is obligated for an additional period to maintain an aggregate of
5,000 jobs, inclusive of those we create.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
LEXICON GENETICS INCORPORATED
Date: July 18, 2005 By: /s/ JEFFREY L. WADE
-------------------------------
Jeffrey L. Wade
Executive Vice President and
General Counsel